Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127541501 | 12754150 | 1 | I | 20160906 | 20160916 | 20160916 | PER | US-ASTRAZENECA-2016SE95569 | ASTRAZENECA | 0.00 | F | Y | 47.60000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127541501 | 12754150 | 1 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127541501 | 12754150 | 2 | PS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | 204760 | 25 | MG | TABLET | QOD | ||||||
| 127541501 | 12754150 | 3 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | U | 204760 | 12.5 | MG | TABLET | QOD | ||||||
| 127541501 | 12754150 | 4 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127541501 | 12754150 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127541501 | 12754150 | 6 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127541501 | 12754150 | 7 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127541501 | 12754150 | 8 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 127541501 | 12754150 | 9 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 127541501 | 12754150 | 10 | C | TIMOLOL. | TIMOLOL | 1 | Ophthalmic | 1.0GTT UNKNOWN | 0 | 1 | GTT | ||||||||
| 127541501 | 12754150 | 11 | C | MORPHINE XR | 2 | Oral | 0 | 15 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127541501 | 12754150 | 2 | Constipation |
| 127541501 | 12754150 | 3 | Constipation |
| 127541501 | 12754150 | 4 | Gastrooesophageal reflux disease |
| 127541501 | 12754150 | 5 | Hiatus hernia |
| 127541501 | 12754150 | 8 | Prophylaxis |
| 127541501 | 12754150 | 9 | Prophylaxis |
| 127541501 | 12754150 | 10 | Glaucoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127541501 | 12754150 | Abdominal pain upper | |
| 127541501 | 12754150 | Drug dose omission | |
| 127541501 | 12754150 | Gastrooesophageal reflux disease | |
| 127541501 | 12754150 | Intentional product misuse | |
| 127541501 | 12754150 | Muscle spasms | |
| 127541501 | 12754150 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127541501 | 12754150 | 1 | 2006 | 0 | ||
| 127541501 | 12754150 | 2 | 20160828 | 2016 | 0 | |
| 127541501 | 12754150 | 3 | 2016 | 0 | ||
| 127541501 | 12754150 | 4 | 2006 | 0 | ||
| 127541501 | 12754150 | 5 | 2006 | 0 | ||
| 127541501 | 12754150 | 6 | 2006 | 0 | ||
| 127541501 | 12754150 | 7 | 2006 | 0 | ||
| 127541501 | 12754150 | 8 | 2009 | 0 | ||
| 127541501 | 12754150 | 9 | 2009 | 0 | ||
| 127541501 | 12754150 | 10 | 2008 | 0 |